Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in ...
Natural killer (NK) cells target infected and oncogenic cells, but are difficult to work with in vitro. Discover novel approaches to producing genetically modified NK cells for cell therapy. Natural ...
Building on the success of CAR T cell therapy for treating blood cancers, researchers are developing NK cell therapies that employ the natural ability of these immune cells to eliminate abnormal cells ...
- Proved the excellent anti-tumor efficacy in various solid tumor-bearing animal model SEONGNAM, South Korea--(BUSINESS WIRE)--GICELL announced the data from the preclinical studies on T.O.P. NK ...
NK cells have a crucial role in cancer surveillance and offer a potential avenue for adoptive cell transfer as either mono- or combination immunotherapy. Previous investigations into transferring ...
Discovery of efficient anti-cancer drugs and drug combinations is essential for therapy success. Therefore, it is crucial that new methods for efficient drug efficacy testing are developed to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results